AGIO
Price
$29.24
Change
+$0.12 (+0.41%)
Updated
Mar 28, 6:59 PM EST
34 days until earnings call
BCYC
Price
$24.90
Change
+$0.35 (+1.43%)
Updated
Mar 28, 6:59 PM EST
34 days until earnings call
Ad is loading...

Analysis and predictions AGIO vs BCYC

Header iconAGIO vs BCYC Comparison
Open Charts AGIO vs BCYCBanner chart's image
Agios Pharmaceuticals
Price$29.24
Change+$0.12 (+0.41%)
Volume$250.14K
CapitalizationN/A
Bicycle Therapeutics
Price$24.90
Change+$0.35 (+1.43%)
Volume$129.58K
CapitalizationN/A
View a ticker or compare two or three
AGIO vs BCYC Comparison Chart

Loading...

AGIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AGIO vs. BCYC commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Hold and BCYC is a Hold.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (AGIO: $29.20 vs. BCYC: $24.90)
Brand notoriety: AGIO and BCYC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 42% vs. BCYC: 54%
Market capitalization -- AGIO: $1.64B vs. BCYC: $943.22M
AGIO [@Biotechnology] is valued at $1.64B. BCYC’s [@Biotechnology] market capitalization is $943.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 0 FA rating(s) are green whileBCYC’s FA Score has 0 green FA rating(s).

  • AGIO’s FA Score: 0 green, 5 red.
  • BCYC’s FA Score: 0 green, 5 red.
According to our system of comparison, both AGIO and BCYC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 4 TA indicator(s) are bullish while BCYC’s TA Score has 5 bullish TA indicator(s).

  • AGIO’s TA Score: 4 bullish, 5 bearish.
  • BCYC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than AGIO.

Price Growth

AGIO (@Biotechnology) experienced а -3.44% price change this week, while BCYC (@Biotechnology) price change was -3.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

AGIO is expected to report earnings on May 02, 2024.

BCYC is expected to report earnings on May 02, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AGIO with price predictions.
OPEN
A.I.dvisor published
a Summary for BCYC with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
AGIO($1.64B) has a higher market cap than BCYC($943M). BCYC YTD gains are higher at: 37.721 vs. AGIO (31.118). BCYC has higher annual earnings (EBITDA): -169.4M vs. AGIO (-384.86M). AGIO has more cash in the bank: 777M vs. BCYC (526M). BCYC has less debt than AGIO: BCYC (45M) vs AGIO (72M). BCYC (27M) and AGIO (26.8M) have equivalent revenues.
AGIOBCYCAGIO / BCYC
Capitalization1.64B943M174%
EBITDA-384.86M-169.4M227%
Gain YTD31.11837.72182%
P/E RatioN/AN/A-
Revenue26.8M27M99%
Total Cash777M526M148%
Total Debt72M45M160%
FUNDAMENTALS RATINGS
AGIO: Fundamental Ratings
AGIO
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGIOBCYC
RSI
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
72%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
73%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
AGIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SDGRX109.06N/A
N/A
DWS Capital Growth R
DPUYX9.02N/A
N/A
BNY Mellon US Equity Y
AMTRX9.03N/A
N/A
AB All Market Real Return R
PAWAX69.58-0.02
-0.03%
T. Rowe Price All-Cap Opportunities-Adv
AMGAX14.31-0.01
-0.07%
Alger Mid Cap Growth A

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PHIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+1.43%
PHIO - BCYC
41%
Loosely correlated
-6.35%
MLTX - BCYC
39%
Loosely correlated
+0.04%
ABUS - BCYC
37%
Loosely correlated
-0.38%
ORMP - BCYC
35%
Loosely correlated
+3.55%
SAGE - BCYC
34%
Loosely correlated
-1.68%
More